Bentham Science Logo

Track Your Manuscript:

Current Medicinal Chemistry

Volume 28, 42 Issues, 2021
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access

Meet the Executive Guest Editor(s)

Pankaj Attri
Center of Plasma Nano-interface Engineering
Kyushu University
Dr. Pankaj Attri is an Associate Professor at the Center of Plasma Nano-Interface Engineering, Kyushu University, Japan. Dr. Attri obtained his Ph.D. from the Department of Chemistry, University of Delhi, India, in 2013. He worked as an Assistant Professor at Department of Electrical and Biological Physics and in Plasma Bioscience research center, Kwangwoon University, Korea, from 2013-2017. Dr. Attri has received many honors such as long term fellowship at Kyushu University, Japan, in 2016. Dr. Attri is the author of more than 90 publications and 8 book chapters of reputed publishers and has earned 4 Patents. Dr. Attri is currently working as an Editorial Board Member of Scientific Reports Journal in Chemical Physics panel.

Sergey O. Bachurin
Institute of Physiologically Active Compounds
Russian Academy of Sciences (RAS)
Professor Sergey Bachurin received the Ph.D. degree in 1980 and Doctor of science degree in 1994 in Moscow State University. Since 1981, he is working at the Institute of Physiologically Active Compounds Russian Academy of Sciences (RAS) in Chernogolovka city. From 2006 till 2018 he remained the Director of the Institute. Since January 2019, he is a scientific supervisor of IPAC RAS and Head of the Department of Medicinal and Biological Chemistry. In 2003, he was elected as a member of Russian Academy of Sciences. His research activity related to the discovery of novel agents for neurodegenerative diseases treatment, in particular for Alzheimer’s disease. He is the main author of the investigative drug for Alzheimer’s disease Dimebon, which successfully passed Phase 2 clinical trials on AD patients (Lancet 2008,372(9634):207-15) and number of novel neuroprotective agents that have passed preclinical trials (Mol Neurobiol. 2018,55(1):335; Sci Rep. 2015, 2017, 2019). He is the author of more than 250 articles in peer-reviewing journals and about 40 patents. His h-index is 29 in WoS datebase. Bachurin was an invited lecturer at the University of California (San Francisco), and at the Tufts University (Boston). He is the Chairman of Scientific Council of RAS on “Medicinal Chemistry”, Head of Moscow Chemical Society and Council member of European Federation of Medicinal Chemistry.

Simone Brogi
Department of Pharmacy
University of Pisa
Simone Brogi is an Assistant Professor in the Department of Pharmacy at the University of Pisa, Italy. He graduated in 2005 in Biological Sciences from the University of Siena, where he also received his PhD in Pharmaceutical Sciences in 2010. From 2011 to 2019 he has directed the Molecular Modeling Unit at the Department of Biotechnology, Chemistry and Pharmacy (University of Siena) in the research group of Prof. Giuseppe Campiani. Dr Brogi has sound knowledge of various computational methodologies: Pharmacophore modeling, Virtual Screening, High throughput Docking, High throughput QM-Polarized Ligand Docking, Molecular Docking, Homology Modeling, 3D-QSAR and 3D-QSSR models, Molecular Dynamics, QM/MM calculations, in silico prediction of ADME+T Properties. Furthermore, Dr Brogi possesses expertise in GPU calculation by means of CUDA technology applied to Molecular Dynamics software. His research activity, described in over 100 papers (full list of publications:, is focused on computational approaches for the discovery and optimization of small-molecules with therapeutic potential for treating cancer and pain, neurodegenerative, cardiovascular, and parasitic diseases. Moreover, the mentioned research interest also comprises innovative in silico strategies to establish the pharmacokinetics and pharmacodynamics profile of potential drug candidates. Dr Brogi is the head of in silico Pharmacology and Toxicology Unit at University of Pisa in the research group of Prof. Vincenzo Calderone.

Rodrigo V. Báez
Canada-University of Toronto
Dr. Rodrigo Valenzuela Báez is an Associate Professor at the University of Chile. He completed his PhD at the Department of Nutrition, University of Toronto, Canada. His research interests include lipids in foods, diet induced obesity and liver steatosis models, cytoprotective effect of bioactive compounds, clinical trials related with fatty acid metabolism and dairy products in human nutrition. Dr. Rodrigo Valenzuela has authored over 70 publications in peer-reviewed journals and in 15 books of diverse topics.

Gaetano Caramori
University of Messina
Dr. Gaetano Caramori, MD, PhD, is a Full Professor in Respiratory Medicine, at the Dipartimento di Scienze BIOMORF, University of Messina, Italy. He is serving as Head of the Pulmonology Unit at the University Hospital Gaetano Martino, and also Head of the Specialization School in Respiratory Diseases at the University of Messina, Italy. Dr. Gaetano Caramori is an honorary staff member at the Airway Disease Section of the National Heart and Lung Institute, Imperial College of London, UK, since 2001. He has published about 160 articles in International Scientific peer-reviewed Journals, including all the major Journals of the Respiratory System. His research interests have focused on DNA damage repair in the lungs, bronchial asthma and chronic obstructive pulmonary disease (COPD).

Guido Crisponi
University of Cagliari
Dr. Guido Crisponi is a Full Professor of Analytical Chemistry at Cagliari University, Italy. The majority of Dr. Crisponi works deal with analytical studies on the distribution of toxic elements in various human tissues, solution equilibria studies on the interaction between metal ions and bio-molecules by potentiometric, spectrophotometric and NMR techniques. In the last twenty years, his research group has been mainly involved in studies concerning chelation therapy to treat the toxic effects of metal ions in humans. He is a member of the Editorial Board of various international journals and is the author of more than 170 publications.

Xianting Ding
Jiao Tong University
Dr. Xianting Ding is a Professor at the School of Biomedical Engineering and is the Deputy Director of Institute for Personalized Medicine, Shanghai Jiao Tong University, China. He received his Ph.D. from the Department of Mechanical Engineering at University of California, Los Angeles, USA. His research interests are single cell protein analysis, personalized medicine with trace clinical specimens and portable bio-sensors with microfluidics. He participated in the early development of 3 multi-million-USD international research centers. He is part of the Editorial Board for Scientific Reports and SLAS Technology (JALA) and is the reviewer for 20 SCI journals. Dr. Xianting Ding is the author of 90 peer-reviewed SCI papers and has filed 30 national and international patents.

Hao Lin
University of Electronic Science and Technology of China (UESTC)
Dr. Hao Lin is a Professor of the Center for Informational Biology at the University of Electronic Science and Technology of China. He received his Ph.D. from Inner Mongolia University, P.R. China in 2007. His researches focused on Bioinformatics and Systems Biology. He has published over 110 peer-reviewed papers in SCI-indexed journals.

Kuen-Song Lin
Yuan Ze University
Taoyuan City
Dr. Kuen-Song Lin is a Senior Professor of the Department of Chemical Engineering and Materials Science, Yuan Ze University, Taiwan. He is also the Director of Environmental Technology Research Centre (ETRC) and the Dean of Research and Development (R&D office) in Yuan Ze University. His research topics include waste reutilization, on-site soil and water pollution remediation, environmental and photocatalytic catalyst preparation technologies, hydrogen storage, carbon capture and sustainable energy generation. Dr. Lin has published more than 150 articles in peer-reviewed journals.

Cristina Maccallini
Department of Pharmacy
University of Chieti
Cristina Maccallini received her PhD in Pharmaceutical Sciences in 2002 from the University of Chieti, where she is currently assistant professor at the Department of Pharmacy. Her main research interests is focused on the design, synthesis and biological evaluation of small molecules targeting proteins involved in inflammation and cancer development, such as the inducible Nitric Oxide Synthase, the Carbonic Anhydrases, the Aromatase and PPARs. She is author of over 60 publications in the Medicinal Chemistry field and 1 book chapter. She is a member of the Editorial Board of various international journals and member of the Italian Chemistry Society.

Massimo Pancione
University of Sannio
Massimo Pancione received his B.A. degree in Biochemistry from the University of Naples Federico II (Italy) and his Ph.D. degree from the University of Sannio (Italy). He completed his research training at National Research Council (Italy) and the Spanish National Cancer Research Center (Spain), working on mice models of intestinal disease and cancer. He is currently a Researcher of Molecular Biology and Head of the Laboratory of Molecular Oncology and Signal Transduction at the Department of Science and Technology, University of Sannio, Italy. In recent years, his research has focused on understanding the molecular mechanisms by which cancer cells of aggressive human tumors grow and remain hidden to metastasize in other organs.

Jelena Popovic-Djordjevic
Department Chemistry and Biochemistry
University of Belgrade
Dr. Jelena Popović-Djordjević is a Professor of Organic Chemistry in the Faculty of Agriculture at the University of Belgrade, Serbia. She graduated from the University of Belgrade, where she received her B.A. degree in Applied Chemistry and her Ph.D. degree in Organic Chemistry in 2010. She is the author of more than 150 publications in leading international peer-reviewed journals, 2 book chapters and 40 papers on the international and national conferences. Her main research is related to Natural Products, Biological activity of Natural and Synthetic Compounds, Food Chemistry and Environmental Chemistry. She is a member of the Serbian Chemical Society, the Serbian Water Protection Society and the Editorial board member of Ecological Safety and Balanced Use of Resources.

Christos Savopoulos
Aristotle University of Thessaloniki
Dr. Christos Savopoulos received his Ph.D. in 2002 from the Medical School, Aristotle University of Thessaloniki, Greece. He currently serves as a Professor of Internal Medicine at the Aristotle University of Thessaloniki and also as the Head of the first Medical Propaedeutic Department of Internal Medicine at AHEPA University Hospital. He was one of the principal establishers of a Stroke Unit in the University Hospital of AHEPA, Thessaloniki, Greece, and thereafter the Head of this Stroke Unit. He is a member of 17 Greek and International Medical Scientific Societies, Associations and Working Groups. Dr. Christos Savopoulos has authored about 140 publications in international journals and 27 book chapters.

Xinhua Shu
Glasgow Caledonian University
Dr. Xinhua Shu is an Associate Professor at Department of Biological and Biomedical Sciences, Glasgow Caledonian University, Scotland. He received his PhD in Pathobiology from the Hunan Medical University, China, in 1999. He received the honor of Fellowship at the University of Glasgow (1999-2001), Scotland, where he worked on the Human Pathogen Paracoccidioides Brasiliensis. In 2001, he was appointed at MRC Human Genetics Unit, Edinburgh, Scotland, to work as an Investigator Scientist for five years and then Senior Investigator Scientist. His research interests are Diabetic Retinopathy, Retinal diseases, the Disease Mechanisms of Retinitis Pigmentosa (RP) and age related macular degeneration (AMD). Dr. Shu has about 110 publications.

Tatjana P. Stanojković
Department of Experimental Oncology
Institute for Oncology and Radiology of Serbia
Tatjana Stanojković was born in Belgrade on June 26, 1966. She graduated from the Faculty of Biology of the University of Belgrade, Department of Molecular Biology and Physiology. She has been employed at the Institute of Oncology and Radiology of Serbia since 1997, since July 2014, as head of the Department of Biological Response Laboratory, Department of Experimental Oncology. Field of expertise: Experimental oncology, Medicinal Chemistry, in vitro investigation of the anticancer activity of novel synthesized compounds, natural product and marine organisms. Member of the Editorial Board, BMC Complementary and Alternative Medicine since 2012.

Jacopo Troisi
University of Salerno
Dr. Jacopo Troisi is Adjunct Professor for Ph.D programme in translational medicine at Salerno University (Italy). He is a research scientist and COO at the European Biomedical Research Institute of Salerno (EBRIS), co-founded by the Harvard University and the Salerno Medical School. He is also co-founder and CEO at Theoreo srl, a spin-off company of the University of Salerno. Dr. Troisi research is related to metabolomics. In particular, he is studying the metabolomic fingerprint of several human disease as a diagnostic tool and as a mechanistic hypothesis generator. He got several international patents and awards for diagnostic tests based on metabolomic profiling.”

Chi-Meng Tzeng
Xiamen University
Dr. Chi-Meng Tzeng is a Full Professor of Pharmaceutical Sciences at Xiamen University, China. He served the Chinese military as an MD Captain in Tri-Service General Hospital (1993-1995). He then received graduated training in Biochemistry, Microbiology and Immunology from Stanford University Medical School, USA, (1995-2000). Dr. Tzeng was appointed as principal Investigator in Medical R&D and industrialization at Academic Sinica (Taiwan) and at National Taiwan University Hospital (2000-2005). His research interests include Translational Medicine among Liquid Biopsy, Microbiota, Neoantigen, Immune-Cell Therapy, AI-Big Data, Herbal Medicine and Combination Theranostics. Dr. Tzeng has authored over 60 SCIs, 4 book chapters, and 13 patents and is also responsible for 14 commercial products, IVDs, supplements and medication.

Yun-Long Wu
Xiamen University
Dr. Wu’s current research interests focus on the development of functional polymeric materials for pharmaceutical applications in terms of controllable drug delivery or gene delivery, with over 70 publications on Angew. Chem. Int. Ed., ACS Nano, Adv. Mater., Small, Adv. Healthcare Mater., Biomacromolecules etc and personal H-index of 25 (Google Scholar).

Kang Xu
Department of Cardiovascular Surgery
Hubei University of Chinese Medicine
Dr. Kang Xu received his M.M. degree from Hubei University of Chinese Medicine and his Ph.D. degree from Chongqing University, China. He studied Stem Cell Engineering and Molecular Therapy as a researcher in University of California, USA. Currently, he is serving as an Associate Professor at the Hubei University of Chinese Medicine. His research interests are Chemical Based Therapeutic Mechanism on Cardiovascular Diseases, Anti-Inflammation Activity on Arthritis of Natural Synthesized Compounds, Wound Repair and Regeneration. Dr. Kang Xu is the author of over 30 publications on Phytotherapy research, Frontiers in Pharmacology, Cell Proliferation, Wound Repair, Regeneration and Pharmaceutical Biology.

Chun Yang
Department of Anesthesiology and Perioperative Medicine
Nanjing Medical University
Dr. Chun Yang, Professor, deputy director at Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University. He received the M.D. degree from Xuzhou Medical University in 2008, M.S. degree from Nanjing University in 2012, and Ph.D. degree from Chiba University, Japan, in 2016. Dr. Yang’s research interests include the antidepressant effects of ketamine and therapeutic strategy for heart failure.

Peng Zhan
Department of Medicinal Chemistry
Shandong University
Dr. Peng Zhan is currently working as Associate Professor in Shandong University. In 2012, he was appointed as a JSPS Postdoctoral Fellow in Kyoto Prefectural University of Medicine, Japan. His research area involves discovery of novel antiviral anticancer and neurodegenerative diseases-related agents based on the rational drug design approaches. So far, he has published more than 100I academic papers, more than 20 patents as co-inventor, and received the first prize of Shandong Province Science (2010), CPA-Servier Young Investigator Awards in Medicinal Chemistry (2016), and and many other honors and awards.

Kun Zhang
Department of Medical Ultrasound
Tongji University School of Medicine
Prof. Kun Zhang is a Research Fellow and a PhD advisor who comes from Shanghai Tenth Peoples’ Hospital. Nowadays, he is the Deputy Director of Ultrasound Research and Education Institute, Tongji University, School of Medicine. He has published 18 SCI papers as the first author or corresponding author in different journals. He has been chosen as the reviewer of some top journals including Advanced Materials, ACS Nano, Advanced Functional Materials Advanced Sciences, Biomaterials, ACS Applied Materials & Interfaces, and Theranostics. He is also elected as the members or committee members of several academic organizations. He is engaged in molecular imaging and corresponding probe design involving MRI, fluorescence imaging and ultrasound imaging as well as multi-modal imaging, and he is also an expert in immunotherapy, gene editing, tumour microenvironment modulation & monitoring, regenerative medicine, nanomedicine and interdisciplinary research.


Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
View Full Editorial Board

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

COPE Compliant

Cope Logo

Journal History

Current Medicinal Chemistry was introduced in 1994 with the assistance of Dr. Atta-ur-Rahman, who is the current Editor-in-Chief serving since 1994.

Related Journals

Related eBooks

eBooks Catalog